Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.

African health sciences - 1 Dec 2014

Waiswa Musa, Seremba Emmanuel, Ocama Ponsiana, Ddungu Henry, Opio Keneth, Okello Clement, O'shea Timothy, Verhovsek Madeleine, Mutyabule Richard

Abstract excerpt

INTRODUCTION: Splanchnic venous thrombosis (SVT) has varied etiology with Philadelphia-negative myeloproliferative neoplasms (MPNs) being the most frequent underlying prothrombotic factor. Hematological indices often remain within normal range because of portal hypertension and its sequelae, causing diagnostic challenges. The high frequency of JAK2 mutation among patients with SVT reinforces the diagnostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatal Outcome
Share to Hematologic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Myeloproliferative Disorders

Share to Philadelphia Chromosome

Share to Portal Vein

Share to Ultrasonography, Doppler

Share to Venous Thrombosis

Source

Open in PubMed Open full text

Identifiers

PMID: 25834519
DOI: 10.4314/ahs.v14i4.39
PMCID: PMC4370089

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.PMID 25834519Read ↗

Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights.Semantic proximity Read ↗

Splanchnic Vein Thrombosis in Myelofibrosis-An Underappreciated Hallmark of Disease Phenotype.Semantic proximity Read ↗

Splanchnic vein thrombosis in myeloproliferative neoplasms.Semantic proximity Read ↗

The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective.Semantic proximity Read ↗

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.Semantic proximity Read ↗

Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.Semantic proximity Read ↗

Clinical features of patients with Philadelphia-negative myeloproliferative neoplasms complicated by portal hypertension.Semantic proximity Read ↗

[Visceral Vein Thrombosis of Myeloproliferative Neoplasm --Review].Semantic proximity Read ↗

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.Semantic proximity Read ↗

Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis.Semantic proximity Read ↗

Portal vein thrombosis as the presenting manifestation of JAK2 positive myeloproliferative neoplasm.Semantic proximity Read ↗

JAK2V617F mutation in patients with splanchnic vein thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.